Evidence map›Paper›PMID 41304151›Full record

ReviewMicroorganisms2025

Fecal Microbiota Transplantation in Animals: Therapeutics, Conservation, and Farming.

Kelly R Reveles, Joni Meehan, Glenn Tillotson

Abstract readReview
In one paragraph

Review in Microorganisms, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Kelly R RevelesCollege of Pharmacy, The University of Texas at Austin, Austin, TX 78712, USA.ORCID 0000-0001-8880-4879
Joni MeehanGST Micro, LLC, North, VA 23128, USA.
Glenn TillotsonGST Micro, LLC, North, VA 23128, USA.

Funding

Institute for Integration of Medicine & Science: A Partnership to Improve HealthUM1TR004538 · NCATS · UNIVERSITY OF TEXAS HLTH SCIENCE CENTER · PI ROBERT A CLARK, Kenneth M Hargreaves · 2023 to 2026
$22.3M
Microbiome-mediated therapies for aging and healthspan in marmosetsR01AG065546 · NIA · TEXAS BIOMEDICAL RESEARCH INSTITUTE · PI REVELES, KELLY RENEE, ROSS, CORINNA NICOLE · 2020 to 2024
$3.4M
NCATS NIH HHS UM1 TR004538NIA NIH HHS R01 AG065546
6 · The paper itself

Abstract

Fecal microbiota transplantation (FMT) is increasingly used in both human and veterinary settings to restore gut microbiota and promote health. Advances in sequencing technologies and microbiome analysis have expanded our understanding of microbial communities and enabled broader FMT applications. As insights grow into what constitutes a healthy microbiome, interest in using FMT across a range of animal contexts has also increased. This narrative review highlights recent progress in the use of FMT to improve the welfare of farm animals, manage infectious and chronic conditions in companion animals, and support the health of wildlife in conservation and reintroduction programs. Representative examples from each domain are discussed.

Indexed as

animal healthconservation biologyfecal microbiota transplantationmicrobiomeveterinary medicine

Identifiers

PMID41304151
PMCPMC12654824

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.